W
BSX icon

WealthStone’s Boston Scientific BSX Stock Holding History

WealthStone’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$283K Buy
7,341
+773
+12% +$29.3K 0.1% 174
2020
Q4 		$236K Sell
6,568
-606
-8% -$21.8K 0.08% 179
2020
Q3 		$274K Buy
+7,174
New +$276K 0.13% 115
2019
Q3 		– Sell
-15,787
Closed -$679K – 136
2019
Q2 		$679K Buy
15,787
+15,535
+6,165% +$598K 0.3% 67
2019
Q1 		$10K Buy
+252
New +$9.63K 0.36% 16

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

WealthStone's BSX Position: Q1 2021 in Review

WealthStone increased its Boston Scientific (BSX) stake by 12% in Q1 2021, buying an estimated $29.3K and bringing the position to 7,341 shares worth $283K. The position accounts for 0.1% of the portfolio, ranked #174.

WealthStone first reported a position in BSX in Q1 2019 and has held it in 5 quarters since. The position peaked at $679K in Q2 2019. 830 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • WealthStone held 7,341 shares of Boston Scientific worth $283K as of Q1 2021.
  • WealthStone bought 773 Boston Scientific shares in Q1 2021, an estimated $29.3K.
  • Boston Scientific made up 0.1% of WealthStone's portfolio in Q1 2021, its #174 holding.
  • WealthStone first reported a position in Boston Scientific in Q1 2019 and has held it in 5 quarters since.
  • WealthStone's Boston Scientific position peaked at $679K in Q2 2019.
  • 830 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on WealthStone's 13F filing for Q1 2021, filed 13 May 2021.